Graft Vasculopathy
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Evaluation of the Effect of Fluvastatin 40 mg (b.i.d.) in the Prevention of the Development of Vasculopathy of the Graft in de Novo Renal Transplant Patients Transplant (NCT00565474) | Novartis Pharmaceuticals | 2001-09-01 |
Track Graft Vasculopathy automatically
Every clearance here is in the API, with alerts when new ones post.